Lisette Binkhorst

481 total citations
14 papers, 365 citations indexed

About

Lisette Binkhorst is a scholar working on Genetics, Pharmacology and Pharmacology. According to data from OpenAlex, Lisette Binkhorst has authored 14 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Lisette Binkhorst's work include Estrogen and related hormone effects (9 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Inflammatory mediators and NSAID effects (5 papers). Lisette Binkhorst is often cited by papers focused on Estrogen and related hormone effects (9 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Inflammatory mediators and NSAID effects (5 papers). Lisette Binkhorst collaborates with scholars based in Netherlands. Lisette Binkhorst's co-authors include Ron H.J. Mathijssen, Teun van Gelder, Agnes Jager, Erik A.C. Wiemer, Peter de Bruijn, M. Bannink, Walter J. Loos, Myrthe P. P. van Herk‐Sukel, Paul Hamberg and Robbert J. van Alphen and has published in prestigious journals such as Annals of Oncology, Pharmaceutical Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Lisette Binkhorst

14 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisette Binkhorst Netherlands	11	191	162	106	69	59	14	365
Simone Tchu United States	7	249 1.3×	225 1.4×	133 1.3×	90 1.3×	75 1.3×	8	421
A Trovato United States	8	193 1.0×	184 1.1×	125 1.2×	70 1.0×	137 2.3×	16	577
Masaki Kumondai Japan	12	91 0.5×	270 1.7×	126 1.2×	46 0.7×	148 2.5×	34	434
Martin Perreault Canada	12	75 0.4×	70 0.4×	90 0.8×	31 0.4×	111 1.9×	21	374
Andrea S. Blevins‐Primeau United States	6	101 0.5×	204 1.3×	95 0.9×	49 0.7×	146 2.5×	8	339
Ryan Whaley United States	6	143 0.7×	268 1.7×	57 0.5×	66 1.0×	237 4.0×	9	606
Eiji Hishinuma Japan	14	77 0.4×	139 0.9×	131 1.2×	35 0.5×	308 5.2×	45	583
Jacqueline Marti-Jaun Switzerland	10	48 0.3×	198 1.2×	92 0.9×	85 1.2×	128 2.2×	15	463
Reynold C. Ly United States	12	104 0.5×	222 1.4×	77 0.7×	18 0.3×	131 2.2×	23	394

Countries citing papers authored by Lisette Binkhorst

Since Specialization

Citations

This map shows the geographic impact of Lisette Binkhorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisette Binkhorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisette Binkhorst more than expected).

Fields of papers citing papers by Lisette Binkhorst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisette Binkhorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisette Binkhorst. The network helps show where Lisette Binkhorst may publish in the future.

Co-authorship network of co-authors of Lisette Binkhorst

This figure shows the co-authorship network connecting the top 25 collaborators of Lisette Binkhorst. A scholar is included among the top collaborators of Lisette Binkhorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisette Binkhorst. Lisette Binkhorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hussaarts, Koen G. A. M., Lisette Binkhorst, Esther Oomen‐de Hoop, et al.. (2019). The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors. Pharmaceutical Research. 37(1). 7–7. 9 indexed citations

Binkhorst, Lisette, et al.. (2018). Short article: Switching to a infliximab biosimilar: short-term results of clinical monitoring in patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology. 30(7). 699–703. 18 indexed citations

Doorn, Leni van, et al.. (2016). Capecitabine and the Risk of Fingerprint Loss. JAMA Oncology. 3(1). 122–122. 13 indexed citations

Kloth, Jacqueline S. L., Lisette Binkhorst, Peter de Bruijn, et al.. (2015). Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence. Clinical Pharmacokinetics. 54(8). 851–858. 20 indexed citations

Binkhorst, Lisette. (2015). Tamoxifen Pharmacokinetics Beyond the Genotyping Era. Data Archiving and Networked Services (DANS). 1 indexed citations

Binkhorst, Lisette, Ron H.J. Mathijssen, Agnes Jager, & Teun van Gelder. (2015). Individualization of tamoxifen therapy: Much more than just CYP2D6 genotyping. Cancer Treatment Reviews. 41(3). 289–299. 83 indexed citations

Binkhorst, Lisette, Jacqueline S. L. Kloth, Peter de Bruijn, et al.. (2015). Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients. Breast Cancer Research and Treatment. 152(1). 119–128. 30 indexed citations

Binkhorst, Lisette, M. Bannink, Peter de Bruijn, et al.. (2015). Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch. Clinical Pharmacokinetics. 55(2). 249–255. 21 indexed citations

Heine, Rob ter, Lisette Binkhorst, Peter de Bruijn, et al.. (2014). Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen. British Journal of Clinical Pharmacology. 78(3). 572–586. 22 indexed citations

10.

Binkhorst, Lisette, M. Bannink, Peter de Bruijn, et al.. (2014). First Intra-Patient Comparison of Antidepressant Use Among Tamoxifen Patients. Annals of Oncology. 25. iv106–iv106. 2 indexed citations

11.

Binkhorst, Lisette, Ron H.J. Mathijssen, Myrthe P. P. van Herk‐Sukel, et al.. (2013). Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen. Breast Cancer Research and Treatment. 139(3). 923–929. 49 indexed citations

12.

Binkhorst, Lisette, Teun van Gelder, & Ron H.J. Mathijssen. (2012). Individualization of Tamoxifen Treatment for Breast Carcinoma. Clinical Pharmacology & Therapeutics. 92(4). 431–433. 30 indexed citations

13.

Binkhorst, Lisette, Teun van Gelder, Walter J. Loos, et al.. (2012). Effects of CYP Induction by Rifampicin on Tamoxifen Exposure. Clinical Pharmacology & Therapeutics. 92(1). 62–67. 29 indexed citations

14.

Binkhorst, Lisette, Ron H.J. Mathijssen, Peter de Bruijn, et al.. (2011). Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 56(5). 1016–1023. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact